InvestorsHub Logo

zoomlik

01/08/18 7:20 PM

#1070 RE: ehihub #1069

I think $5 price target is based on $8,000 treatment price. I think for this critically ill patient population, until there is alternative to AmpliPhi’s RX, APHB can command a premium to $8,000